TrialAnnals of the rheumatic diseases2004

Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis.

R Alten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.